-
Lupin Atlantis Holdings S.A. v. Mylan Inc. et al DC CAFC
- 1:11-cv-03893
- S.D.N.Y.
- Judge: Jed Saul Rakoff
- Filed: 06/08/2011
- Closed: 12/28/2012
- Latest Docket Entry: 08/20/2013
- PACER
- Docket updated daily
1
Plaintiff
3
Defendants
1
Accused
Product
2
Patents-in-Suit
652
Days in
Litigation
-
Lupin Atlantis Holdings S.A. v. Mylan Inc. et al DC CAFC
- 1:11-cv-03893
- S.D.N.Y.
- Judge: Jed Saul Rakoff
- Filed: 06/08/2011
- Closed: 12/28/2012
- Latest Docket Entry: 08/20/2013
- PACER
- Docket updated daily
Cause of Action
Willful Patent Infringement
Market Sector
Biotech and Pharma
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Mylan Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Fenofibrate 43 mg, 130 mg capsules | US 7,101,574 B1 | All Asserted Claims |
No infringement
Entry 39
|
| Fenofibrate 43 mg, 130 mg capsules | US 7,863,331 B2 | All Asserted Claims |
No infringement
Entry 39
|
Mylan Pharmaceuticals Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Fenofibrate 43 mg, 130 mg capsules | US 7,101,574 B1 | All Asserted Claims |
No infringement
Entry 39
|
| Fenofibrate 43 mg, 130 mg capsules | US 7,863,331 B2 | All Asserted Claims |
No infringement
Entry 39
|
